Vetoquinol (LTS:0O1O) Dividends Received

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LTS:0O1O Vetoquinol SA LTS:0O1O
80 GF Score
Price €74.50
GF Value €82.70
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is Vetoquinol Dividends Received?

Dividends Received only applicable to companies reporting Cash Flow from Operations in direct method.

LTS:0O1O
80GF Score
Vetoquinol SA LTS:0O1O
Dividends Received is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Vetoquinol (LTS:0O1O) Overvalued in 2026?

Based on GuruFocus' analysis, Vetoquinol stock appears to be undervalued. The current stock price of €74.50 is trading 9.9% below its estimated GF Value™ of €82.70. GuruFocus considers Vetoquinol to be Modestly Undervalued.

Key valuation signals for LTS:0O1O:

  • Dividends Received:
  • GF Value™: €82.70 vs. price of €74.50 (9.9% below fair value)
  • GF Score™: 80/100 with 1 warning sign

No single metric tells the full story. See the LTS:0O1O stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Vetoquinol Business Description

Other Exchanges VETO:France8JM:Germany
Address Magny-Vernois, BP 189, Lure cedex, FRA, 70204
Vetoquinol SA operates is a France-based firm serving in the healthcare market. Its focus lies on developing and marketing veterinary drugs mainly in the European region and to a certain extent in America and Asia. Its portfolio of drugs entails anti-infectives, anti- pain inflammatory drugs, cardiovascular and nephrology treatment intended mainly for pets and livestock.
80GF Score

Get the complete analysis for LTS:0O1O

Dividends Received is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€74.50
Price
€82.70
GF Value